Cargando…

Inflammatory Cytokines in Diabetic Nephropathy

Probably, the most paradigmatic example of diabetic complication is diabetic nephropathy, which is the largest single cause of end-stage renal disease and a medical catastrophe of worldwide dimensions. Metabolic and hemodynamic alterations have been considered as the classical factors involved in th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Donate-Correa, Javier, Martín-Núñez, Ernesto, Muros-de-Fuentes, Mercedes, Mora-Fernández, Carmen, Navarro-González, Juan F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2015
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4345080/ https://www.ncbi.nlm.nih.gov/pubmed/25785280 http://dx.doi.org/10.1155/2015/948417

Ejemplares similares

Inflammatory Targets in Diabetic Nephropathy
por: Donate-Correa, Javier, et al.
Publicado: (2020)

Inflammatory Cytokines in Diabetic Kidney Disease: Pathophysiologic and Therapeutic Implications
por: Donate-Correa, Javier, et al.
Publicado: (2021)

Influence of Klotho gene polymorphisms on vascular gene expression and its relationship to cardiovascular disease
por: Donate‐Correa, Javier, et al.
Publicado: (2015)

Diabetes, Inflammation, Proinflammatory Cytokines, and Diabetic Nephropathy
por: Navarro, Juan F., et al.
Publicado: (2006)

Associations between Inflammation, Hemoglobin Levels, and Coronary Artery Disease in Non-Albuminuric Subjects with and without Type 2 Diabetes Mellitus
por: Donate-Correa, Javier, et al.
Publicado: (2023)

Association of Klotho with Coronary Artery Disease in Subjects with Type 2 Diabetes Mellitus and Preserved Kidney Function: A Case-Control Study
por: Donate-Correa, Javier, et al.
Publicado: (2023)

Selective Vitamin D Receptor Activation as Anti-Inflammatory Target in Chronic Kidney Disease
por: Donate-Correa, J., et al.
Publicado: (2014)

Association between serum levels of Klotho and inflammatory cytokines in cardiovascular disease: a case-control study
por: Martín-Núñez, Ernesto, et al.
Publicado: (2020)

Pathophysiological Implications of Imbalances in Fibroblast Growth Factor 23 in the Development of Diabetes
por: Donate-Correa, Javier, et al.
Publicado: (2021)

Klotho as a biomarker of subclinical atherosclerosis in patients with moderate to severe chronic kidney disease
por: Donate-Correa, Javier, et al.
Publicado: (2021)

Repurposing drugs for highly prevalent diseases: pentoxifylline, an old drug and a new opportunity for diabetic kidney disease
por: Donate-Correa, Javier, et al.
Publicado: (2022)

Pentoxifylline for Renal Protection in Diabetic Kidney Disease. A Model of Old Drugs for New Horizons
por: Donate-Correa, Javier, et al.
Publicado: (2019)

Klotho, Oxidative Stress, and Mitochondrial Damage in Kidney Disease
por: Donate-Correa, Javier, et al.
Publicado: (2023)

FGF23 and Klotho Levels are Independently Associated with Diabetic Foot Syndrome in Type 2 Diabetes Mellitus
por: Donate-Correa, Javier, et al.
Publicado: (2019)

Inflammatory cytokines as predictive markers for early detection and progression of diabetic nephropathy
por: Elmarakby, Ahmed A., et al.
Publicado: (2010)

RELEVANCE OF TNF-α IN THE CONTEXT OF OTHER INFLAMMATORY CYTOKINES IN THE PROGRESSION OF DIABETIC NEPHROPATHY
por: Sun, Lin, et al.
Publicado: (2015)

Correlation analysis of urine proteins and inflammatory cytokines with osteoporosis in patients with diabetic nephropathy
por: Zhao, Zhende
Publicado: (2018)

Klotho inversely relates with carotid intima- media thickness in atherosclerotic patients with normal renal function (eGFR ≥60 mL/min/1.73m(2)): a proof-of-concept study
por: Donate-Correa, Javier, et al.
Publicado: (2023)

Extracellular water/total body water ratio as predictor of mortality in hemodialysis patients
por: Pérez-Morales, Rosa, et al.
Publicado: (2021)

Genetic variants in inflammatory cytokines and angiogenesis associated with diabetic nephropathy- A meta-analysis
por: Siddiqui, Khalid, et al.
Publicado: (2014)

Rack1 regulates pro-inflammatory cytokines by NF-κB in diabetic nephropathy
por: Wu, Keqian, et al.
Publicado: (2022)

Canagliflozin and Renal Events in Diabetes with Established Nephropathy Clinical Evaluation and Study of Diabetic Nephropathy with Atrasentan: what was learned about the treatment of diabetic kidney disease with canagliflozin and atrasentan?
por: Fernandez-Fernandez, Beatriz, et al.
Publicado: (2019)

Role of Klotho and AGE/RAGE-Wnt/β-Catenin Signalling Pathway on the Development of Cardiac and Renal Fibrosis in Diabetes
por: Martín-Carro, Beatriz, et al.
Publicado: (2023)

Renal expression of cytokines and chemokines in diabetic nephropathy
por: Araújo, Liliane Silvano, et al.
Publicado: (2020)

Unravelling the Inflammatory Processes in the Early Stages of Diabetic Nephropathy and the Potential Effect of (S(s))-DS-ONJ
por: Gómez-Jaramillo, Laura, et al.
Publicado: (2022)

MiRNA-29c regulates the expression of inflammatory cytokines in diabetic nephropathy by targeting tristetraprolin
por: Guo, Jia, et al.
Publicado: (2017)

Increased Expression of Circulating Stress Markers, Inflammatory Cytokines and Decreased Antioxidant Level in Diabetic Nephropathy
por: Mansoor, Ghazal, et al.
Publicado: (2022)

Phenotypic Modulation of Cultured Primary Human Aortic Vascular Smooth Muscle Cells by Uremic Serum
por: Cazaña-Pérez, Violeta, et al.
Publicado: (2018)

Fibroblast growth factor 23 expression in human calcified vascular tissues
por: Donate-Correa, Javier, et al.
Publicado: (2019)

The Concept and the Epidemiology of Diabetic Nephropathy Have Changed in Recent Years
por: Martínez-Castelao, Alberto, et al.
Publicado: (2015)

A Novel Heterozygous Deletion Variant in KLOTHO Gene Leading to Haploinsufficiency and Impairment of Fibroblast Growth Factor 23 Signaling Pathway
por: Martín-Núñez, Ernesto, et al.
Publicado: (2019)

Diabetic Nephropathy without Diabetes
por: López-Revuelta, Katia, et al.
Publicado: (2015)

Common Variants of Inflammatory Cytokine Genes Are Associated with Risk of Nephropathy in Type 2 Diabetes among Asian Indians
por: Ahluwalia, Tarunveer Singh, et al.
Publicado: (2009)

Author Correction: MiRNA-29c regulates the expression of inflammatory cytokines in diabetic nephropathy by targeting tristetraprolin
por: Guo, Jia, et al.
Publicado: (2018)

Experimental Models to Study Diabetes Mellitus and Its Complications: Limitations and New Opportunities
por: Martín-Carro, Beatriz, et al.
Publicado: (2023)

Klotho expression in peripheral blood circulating cells is associated with vascular and systemic inflammation in atherosclerotic vascular disease
por: Martín-Núñez, Ernesto, et al.
Publicado: (2022)

Novel Immunomodulatory Cytokine Regulates Inflammation, Diabetes, and Obesity to Protect From Diabetic Nephropathy
por: Sabapathy, Vikram, et al.
Publicado: (2019)

Patterns of Toll-Like Receptor Expressions and Inflammatory Cytokine Levels and Their Implications in the Progress of Insulin Resistance and Diabetic Nephropathy in Type 2 Diabetic Patients
por: Aly, Rofyda H., et al.
Publicado: (2020)

Deterioration of diabetic nephropathy via stimulating secretion of cytokines by atrial natriuretic peptide
por: Liu, Chenxiao, et al.
Publicado: (2021)

The Diabetic Nephropathy and the Development of Hypertension in Rats
por: Zuccollo, Adriana, et al.
Publicado: (2001)

Cannot write session to /tmp/vufind_sessions/sess_7vq8b6vobrrsgq0bus5tm0ppfo